Through
11/26
Meredith Mann
meredith.mann@pennmedicine.upenn.edu
Medicine
DNA vaccine leads to immune responses in HPV-related head and neck cancer
DNA vaccine leads to immune responses in HPV-related head and neck cancer
Researchers from the Abramson Cancer Center find immunotherapy approach can help T cells infiltrate tumors.
Flu vaccination rates in clinics drop as day progresses, but ‘nudges’ give them a boost
Flu vaccination rates in clinics drop as day progresses, but ‘nudges’ give them a boost
A new study shows that nudges prompting staff to create templates for vaccine orders increases flu vaccination rates.
Targeting a viral vulnerability to treat disease
Targeting a viral vulnerability to treat disease
Robert Ricciardi company ViRAZE utilizes interdisciplinary approaches to drug discovery. Its first target is molluscum contagiosum, a disease that targets children and immune-compromised adults with no current FDA-approved therapy.
Finding patterns in a class of neurological disorders
Finding patterns in a class of neurological disorders
Research from Penn Engineering and the Perelman School of Medicine has found that the shared pattern is misfolded in Fragile X Syndrome, a member of the class of disorders that also includes ALS and Huntington’s disease
CAR T cell therapy receives approval for use across European Union
CAR T cell therapy receives approval for use across European Union
The European Commission has approved a personalized cellular therapy developed at the Abramson Cancer Center, making it the first CAR T cell therapy permitted for use in the European Union in two distinct indications.
A promising candidate for a universal flu vaccine
A promising candidate for a universal flu vaccine
A flu vaccine that targets a deeper level of the virus itself may be the key to a universal flu vaccine that is more effective at protecting humans from any strain of flu each season.
New insights into malaria culprit
New insights into malaria culprit
New insights from the Perelman School of Medicine on the origins of deadly infectious diseases are vital to understanding the emergence of human pathogens, and may even lead to eradicating malaria.
New Parkinson’s disease biomarker guidelines invigorates drive for treatments
New Parkinson’s disease biomarker guidelines invigorates drive for treatments
Identifying biomarkers of Parkinson's disease, such as proteins found in blood, is key to discovering treatment for the disease. New guidelines, published in Science and Translational Medicine journal, are the result of a collaboration between researchers with unique expertise outside of academia.
Knockdown and replace: A gene therapy twofer to treat blindness
Knockdown and replace: A gene therapy twofer to treat blindness
More than 150 different mutations in the light-sensing molecule rhodopsin can cause retinitis pigmentosa, characterized by a progressive loss of night and peripheral vision, and a team of researchers have developed a treatment for the condition. Successful results in dogs set the stage for testing in humans.
Drugs in development for cancer may also fight brain diseases, including ALS
Drugs in development for cancer may also fight brain diseases, including ALS
In a study done by researchers at the Perelman School of Medicine and the School of Arts and Sciences, PARP inhibitors, which are used for fighting cancer, can be useful for the treatment and prevention of brain disorders such as ALS.
Media Contact
In the News
The New York Times
Daring Trump, Harris’s campaign releases medical information
Daniel Soffer of the Perelman School of Medicine says that there was no concerning data in Kamala Harris’ released medical report.
FULL STORY →
WHYY (Philadelphia)
Philadelphia health providers and patients seek a new treatment roadmap for sickle cell disease after drug recall
Scott Peslak of the Perelman School of Medicine says that the overall goal is always to keep patients safe while providing care, even if it means recalling a drug that has been on the market for several years.
FULL STORY →
NBC Philadelphia
How Penn Medicine is advancing the field of breast reconstruction
Suhail K. Kanchawala of the Perelman School of Medicine explains the process of breast reconstruction after mastectomy.
FULL STORY →
WHYY (Philadelphia)
Penn researchers develop new gene therapy for previously untreatable eye disorder
Artur Cideciyan of the Perelman School of Medicine and colleagues have developed a new gene therapy to treat Leber’s congenital amaurosis, one of the most common causes of blindness in children.
FULL STORY →
HealthDay News
New gene therapy shows ‘life-changing’ promise for hemophilia B
A clinical trial by Adam Cuker of the Perelman School of Medicine and colleagues finds that a new gene therapy can serve as a sustainable single-dose treatment for people with hemophilia B.
FULL STORY →
Runner’s World
How to treat tight calves for better running
John Vasudevan of the Perelman School of Medicine says that protection of a joint is more important than power across it.
FULL STORY →